FC
COLL icon

FORA Capital’s Collegium Pharmaceutical COLL Stock Holding History

FORA Capital’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-7,797
Closed -$223K – 522
2024
Q4 		$223K Buy
+7,797
New +$258K 0.03% 338
2021
Q2 		– Sell
-1,336
Closed -$32K – 914
2021
Q1 		$32K Sell
1,336
-3,608
-73% -$85.7K 0.01% 621
2020
Q4 		$99K Buy
+4,944
New +$96.5K 0.02% 671
2020
Q2 		– Sell
-1,806
Closed -$29K – 967
2020
Q1 		$29K Sell
1,806
-2,764
-60% -$57K 0.01% 891
2019
Q4 		$94K Buy
+4,570
New +$76.2K 0.01% 760

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

FORA Capital's COLL Position: Q1 2025 in Review

FORA Capital sold out of Collegium Pharmaceutical (COLL) in Q1 2025, closing a stake of 7,797 shares — an estimated $223K sold.

FORA Capital first reported a position in COLL in Q4 2019 and held it in 5 quarters. The position peaked at $223K in Q4 2024. 242 funds tracked by Wall St. Rank hold COLL as of Q1 2025.

  • FORA Capital reported no remaining Collegium Pharmaceutical position as of Q1 2025 after selling out during the quarter.
  • FORA Capital sold 7,797 Collegium Pharmaceutical shares in Q1 2025, an estimated $223K.
  • FORA Capital first reported a position in Collegium Pharmaceutical in Q4 2019 and held it in 5 quarters.
  • FORA Capital's Collegium Pharmaceutical position peaked at $223K in Q4 2024.
  • 242 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2025.

Based on FORA Capital's 13F filing for Q1 2025, filed 14 May 2025.